Business ❯ Economics ❯ Market Trends ❯ Stock Market

Company Valuation

AstraZeneca in Talks With Bristol Myers on Potential $400 Billion Merger

AstraZeneca's pursuit of greater U.S. scale could trigger intense antitrust scrutiny.

Jana Partners, Travis Kelce Take 9% Stake in Six Flags, Launch Early Activist Push